EUVIMEDEUVIMED entdecken
Open Access

Development of Potent and Highly Selective Epoxyketone‐Based Plasmodium Proteasome Inhibitors

Jehad Almaliti, Pavla Fajtová, Jaeson Calla, Gregory M LaMonte, Mudong Feng, Frances Rocamora, Sabine Ottilie, Evgenia Glukhov, Evzen Boura, Raymond T Suhandynata, Jeremiah D Momper, Michael K Gilson und 3 weitere

Chemistry – A European Journal · 2023

DOI: 10.1002/chem.202203958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2023. Verfasst von Jehad Almaliti und 14 weiteren Autor:innen. Beteiligte Einrichtung: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA. Hauptthemen laut MEDLINE: Plasmodium, Antimalarials. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here, we present remarkable epoxyketone‐based proteasome inhibitors with low nanomolar in vitro potency for blood‐stage Plasmodium falciparum and low cytotoxicity for human cells. Our best compound has more than 2,000‐fold greater selectivity for erythrocytic‐stage P. falciparum over HepG2 and H460 cells, which is largely driven by the accommodation of the parasite proteasome for a D‐amino acid in the P3 position and the preference for a difluorobenzyl group in the P1 position. We isolated the proteasome from P. falciparum cell extracts and determined that the best compound is 171‐fold more potent at inhibiting the β5 subunit of P. falciparum proteasome when compared to the same subunit of the human constitutive proteasome. These compounds also significantly reduce parasitemia in a P. berghei mouse infection model and prolong survival of animals by an average of 6 days. The current epoxyketone inhibitors are ideal starting compounds for orally bioavailable anti‐malarial drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlasmodiumAntimalarialsMiceAnimalsHumansProteasome InhibitorsProteasome Endopeptidase ComplexPlasmodium falciparum

Stichwörter der Autor:innen

epoxyketoneinhibitionmalariaplasmodiumproteasome

Substanzen

Proteasome InhibitorsProteasome Endopeptidase ComplexAntimalarials

Autor:innen und Institutionen

  • Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA.
  • Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA.
  • Department Pharmaceutical Sciences, College of Pharmacy, University of Jordan, Amman, 11942, Jordan.
  • Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610, Prague, Czech Republic.
  • Department of Pediatrics, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA.
  • Calibr, a division of The Scripps Research Institute, 11119 N Torrey Pines Rd, La Jolla, California, 92093, USA.

Förderung

  • NIH HHS
  • NIGMS NIH HHS
  • NIAID NIH HHS
  • Bill & Melinda Gates Foundation
  • Bill and Melinda Gates Foundation
  • National Institutes of Health
  • St. Baldrick's Foundation

Zitieren

APA

Almaliti, J., Fajtová, P., Calla, J., LaMonte, G. M., Feng, M., Rocamora, F., Ottilie, S., Glukhov, E., Boura, E., Suhandynata, R. T., Momper, J. D., Gilson, M. K., Winzeler, E. A., Gerwick, W. H., & O'Donoghue, A. J. (2023). Development of Potent and Highly Selective Epoxyketone‐Based Plasmodium Proteasome Inhibitors. Chemistry – A European Journal. https://doi.org/10.1002/chem.202203958

Vancouver

Almaliti J, Fajtová P, Calla J, LaMonte GM, Feng M, Rocamora F, et al. Development of Potent and Highly Selective Epoxyketone‐Based Plasmodium Proteasome Inhibitors. Chemistry – A European Journal. 2023. doi:10.1002/chem.202203958

BibTeX
@article{Almaliti2023,
  author = {Almaliti, Jehad and Fajtová, Pavla and Calla, Jaeson and LaMonte, Gregory M and Feng, Mudong and Rocamora, Frances and Ottilie, Sabine and Glukhov, Evgenia and Boura, Evzen and Suhandynata, Raymond T and Momper, Jeremiah D and Gilson, Michael K and Winzeler, Elizabeth A and Gerwick, William H and O'Donoghue, Anthony J},
  title = {Development of Potent and Highly Selective Epoxyketone‐Based Plasmodium Proteasome Inhibitors},
  journal = {Chemistry – A European Journal},
  year = {2023},
  doi = {10.1002/chem.202203958}
}
Kostenlos starten →